Home SEASUN BIOMATERIALS

SEASUN BIOMATERIALS

Korean Based Company to Launch COVID-19 Rapid Molecular Assay

This kit targets ORF1ab gene of SARS-CoV-2 with an endogenous control human RNase P gene. The kit obtained CE-IVD marking in March, and now examinations of an export approval of MFDS (Korea's Ministry of Food & Drug Safety) and the FDA EUA are underway.